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HIV-1 spreads between CD4 T cells most effi-
ciently through virus-induced cell-cell contacts. To
test whether this process potentiates viral spread
by activating signaling pathways, we developed an
approach to analyze the phosphoproteome in in-
fected and uninfected mixed-population T cells
using differential metabolic labeling and mass
spectrometry. We discovered HIV-1-induced activa-
tion of signaling networks during viral spread en-
compassing over 200 cellular proteins. Strikingly,
pathways downstream of the T cell receptor were
the most significantly activated, despite the absence
of canonical antigen-dependent stimulation. The
importance of this pathway was demonstrated by
the depletion of proteins, and we show that HIV-1
Env-mediated cell-cell contact, the T cell recep-
tor, and the Src kinase Lck were essential for
signaling-dependent enhancement of viral dissemi-
nation. This study demonstrates that manipulation
of signaling at immune cell contacts by HIV-1 is
essential for promoting virus replication and defines
a paradigm for antigen-independent T cell signaling.
INTRODUCTION
Many viruses exploit direct cell-cell infection to replicate
most efficiently. HIV-1 is no exception and has evolved to take
advantage of the frequent interactions between immune cells
in lymphoid tissue to disseminate at sites of T cell-T cell contact
(Jolly et al., 2004; Murooka et al., 2012; Sewald et al., 2012).
Indeed, cell-cell spread is the predominant mode of HIV-1 repli-
cation (H€ubner et al., 2009; Jolly et al., 2007b; Martin et al., 2010;
Sourisseau et al., 2007) that ultimately leads to T cell depletion
and the development of AIDS. HIV-1 manipulation of immune
cell interactions in lymphoid tissue, where T cells are densely
packed, allows for rapid HIV-1 spread and evasion of host de-
fenses, including innate (Jolly et al., 2010) and adaptive immunity
(Malbec et al., 2013; McCoy et al., 2014) as well as antiretrovirals
(Agosto et al., 2014; Sigal et al., 2011; Titanji et al., 2013). Impor-
tantly, ongoing viral replication likely prevents an HIV/AIDS cure.
Cell-cell spread of HIV-1 occurs across virus-induced T cell-T1062 Cell Reports 18, 1062–1074, January 24, 2017 ª 2016 The Auth
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is a dynamic, calcium-dependent process that appears highly
regulated (Martin et al., 2010; Groppelli et al., 2015), culminating
in polarized viral egress and rapid infection of neighboring
cells. The molecular details of how HIV-1 co-opts the host cell
machinery to drive maximally efficient spread between permis-
sive T cells remains unclear. Moreover, whether cell-cell spread
induces signals that potentiate viral replication has been little
considered but has major implications for therapeutic and erad-
ication strategies.
Phosphorylation-mediated signaling controls many cellular
functions, including immune cell interactions and cellular re-
sponses to the environment and infection. Quantitative phos-
phoproteomics analysis by mass spectrometry (MS) allows for
global, in-depth profiling of protein phosphorylation kinetics (Ol-
sen et al., 2006). When coupled with functional analysis, such
studies have helped define the pathways leading to T cell activa-
tion, differentiation, and gain of effector function, paving the way
to understanding the molecular details of T cell signaling and the
immune response (Mayya et al., 2009; Navarro et al., 2011; Salo-
mon et al., 2003). So far, analysis of signaling during immune cell
interactions has generally employed reductionist approaches;
for example, cross-linking individual cell-surface proteins such
as the T cell receptor (TCR) or co-stimulatory molecules with
antibody (Matsumoto et al., 2009; Mayya et al., 2009; Navarro
et al., 2011; Ruperez et al., 2012). Such approaches mimic
the process of antigen-dependent stimulation that occurs when
a T cell encounters antigen-presenting cells (APCs) expressing
cognate peptide in the context of major histocompatibility com-
plex (MHC)molecules.However, theunmetchallenge is toglobally
map cellular signaling pathways activated when two cells physi-
cally interact, a more complex setting that recapitulates the un-
characterized complexity of receptor interactions that take place
between immune cells and synergize to drive a cellular response.
Togain insight into themolecularmechanismsunderlyingHIV-1
spread between T cells, we developed an approach that employs
triple SILAC (stable isotype labeling by amino acids in cell culture)
with quantitative phosphoproteomics to map cellular signaling
events simultaneously in two distinct cell populations. We have
used this strategy to perform an unbiased and comprehensive
analysis of how HIV-1 manipulates signaling when spreading
between CD4 T cells. By simultaneously mapping real-time
phosphorylation changes inHIV-1-infected andHIV-1-uninfected
CD4Tcellswith kinetic resolution,we identified the host cell path-
ways and cellular factors modified during HIV-1 dissemination.or(s).
commons.org/licenses/by/4.0/).
Figure 1. Summary of Phosphoproteome
Data
(A) Schematic representation of the screen, work
flow, and analysis.
(B) Top canonical pathways modified in the HIV-1-
infected donor T cell from Ingenuity Pathway
Analysis (IPA) of experiment 1. Magenta circles
indicate proteins with differentially phosphory-
lated phosphosites (>1.5-fold over time). Blue
circles indicate proteins that were identified, but
not differentially phosphorylated, in our study. Size
of circles represents the magnitude of phosphor-
ylation change.
(C) Top canonical pathways modified in the target
T cell from IPA.
(D) Heatmap depicting quantified phosphorylation
sites that demonstrated change in phosphoryla-
tion over time from experiment 1. Yellow color
denotes increased phosphorylation and blue
decreased phosphorylation. Heatmaps were
generated using GProX.
See also Figures S1–S3 and Tables S1, S2, and
S3.Remarkably, our results reveal that HIV-1 subverts canonical
TCR signaling in the absence of antigen to drive spread at
T cell-T cell contacts. Manipulation of T cell signaling by HIV-1
in this way represents a previously unknown strategy to pro-
mote efficient replication with important implications for disease
pathogenesis.
RESULTS
Widespread Global Signaling Changes Induced during
HIV-1 Spread between T Cells
Toobtain anunbiasedandglobal overviewofmanipulationof host
cell signaling during HIV-1 spread, we used SILAC coupled withCell Repoquantitative phosphoproteomics anal-
ysis by MS. Jurkat CD4 T cells, a well-
characterized model of HIV-1 infection
and T cell signaling (Abraham and Weiss,
2004), were labeled using either ‘‘heavy’’
(R10K8) or ‘‘light’’ (R0K0) amino acids
for at least six doublings. SILAC-labeled
R10K8 T cells were infected with HIV-1
by spinoculation to synchronize infec-
tion, achieving 90% infection after 48 hr
(Figure S1A). HIV-1-infected heavy-
labeledanduninfected light-labeled target
T cells were mixed to optimize contacts
(see Supplemental Experimental Proced-
ures) and either lysed immediately (0 min)
or incubated at 37C for 5, 20, or 40 min
prior to lysis to allow for cell-cell contact
and cross-talk (Figures 1A and S1A). We
expected rapid dynamics of cellular
signaling andHIV-1cell-cell spreadduring
T cell-T cell contact (Groppelli et al., 2015;
H€ubner et al., 2009; Jolly et al., 2004). Toenable inter-time-point comparison and temporal analysis of dy-
namic signaling, each time point was supplemented post-lysis
with an internal standard consisting of a pooled sample of mixed
infected and uninfected T cells both labeled with ‘‘medium’’
(R6K4)aminoacidsandcollected fromeach timepoint (Figure1A).
All samples were processed and analyzed byMSwith quantifica-
tion of abundance changes based on MS signal intensities of the
triple-SILAC-labeled peptides. RawMSdata were processed us-
ing MaxQuant for protein assignment, quantification of peptides,
phosphorylation, and phosphosite localization.
We identified a total of 28,853 phosphopeptides correspond-
ing to 5,649 independent proteins (Figures S1A and S1B;
Table S1). This is the largest single dataset from a lymphocyterts 18, 1062–1074, January 24, 2017 1063
Figure 2. HIV-1-Infected T Cells Show Activation of Immune Receptor Signaling Pathways following Cell-Cell Contact
(A) Summary diagram of the TCR, CD28, and iCOS-iCOSL signaling pathways adapted from IPA. Proteins names in red text were identified in our study to be
differentially phosphorylated in HIV-1-infected cells in response to cell-cell contact (refer to Tables S1 and S2). For each phosphorylated protein, the specific
phosphosite modified is indicated with adjacent red text (e.g., Y187, Y202, and Y204 for ERK). Proteins named in black text map to the TCR, CD28, and
(legend continued on next page)
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or hematopoietic cell analysis. We captured proteins across
numerous subcellular localizations, including the cytoplasm
(34.9%), nucleus (47.0%), and plasma membrane (6.2%), in
both T cell populations (Figure S1C). Protein function analysis
revealed a broad spectrum of host cell pathways modified in
both infected and uninfected cells, demonstrating this approach
yields an unbiased capture of the T cell phosphoproteome (Fig-
ure S1D). Phosphorylated serine and threonine were signifi-
cantly more abundant than phosphorylated tyrosine (pS/pT/
pY = 23,073:6,238:502), in agreement with their relative preva-
lence and key role in T cell signaling (Mayya et al., 2009; Navarro
and Cantrell, 2014; Ruperez et al., 2012).
Co-culturing HIV-1-infected (donor) and uninfected T cells
(target) results in >80% of uninfected target T cells becoming
infected by contact-dependent cell-cell spread (Martin et al.,
2010; Sourisseau et al., 2007). To determine the temporal
changes in cellular signaling during HIV-1 spread from donor to
target T cells, we curated the data to consider only high-confi-
dence phosphorylation sites (phosphorylation score of >0.75),
proteins that were identified at all four time points (0, 5, 20,
and 40 min) and those showing >1.5-fold change in the abun-
dance of phosphorylation compared to the internal medium-
labeled reference (Table S2). The relative abundance of phos-
phorylation states for all phosphosites was quantified and the
change over time calculated (Table S2). Statistically significant
changes over time were detected in 938 phosphopeptides
corresponding to 434 proteins in HIV-1 donor cells and 851
phosphopeptides corresponding to 430 proteins in target cells
(Figure S1A; Tables S2-2 and S2-7). Consistent with rapid activa-
tion of signaling pathways, the largest changes in distribution
and frequency of phosphopeptides from both cell populations
were seen within the first 5 min (Figures 1D and S2A–S2D). Tem-
poral signaling changes defined groups of early- and late-
responsive phosphosites and distinct clusters of responsive
proteins, indicative of activation of specific cellular pathways
in each cell population and downstream propagation of signaling
cascades (Figures 1D, S2E, and S2F). To confirm the data
and obviate potential label bias, we repeated the experiment
with reversed SILAC labeling. Phosphorylation changes were
confirmed in 163 phosphopeptides corresponding to 134 pro-
teins in the HIV-1 donor cell (134/434) (Tables S2-4 and S2-5)
and 141 phosphopeptides corresponding to 124 proteins in
the target cell (124/430) (Tables S2-9 and S2-10). This represents
an average 29% overlap between replicate experiments (Table
S2; Figure S3), in excellent agreement with the reproducibility
of similar screens (Navarro et al., 2011). Of these, 108 phosphor-
ylation sites were unique to infected cells (Table S3-1), 86 phos-
phorylation sites were unique to the target cell (Table S3-3), and
55 phosphorylation changes were common to both donors and
targets (Tables S3-2 and S3-4). This implicates specific host
cell factors that may regulate the late steps of viral assembly
and budding (donor cell specific), early infection effects (targetiCOS-ICOSL pathways but were either not identified in our study or did not sho
protein function (e.g., TCR/CD3, immune receptor, phosphatase, kinase, transcr
(B) Overlap between phosphosites identified in our study mapping to top cano
identified as TCR responsive by Mayya et al. (Mayya et al., 2009) and Chylek et
See also Table S4.cell specific) and common factors that may regulate T cell-T
cell interactions and VS formation (overlapping).
Induction of T Cell Receptor Signaling in HIV-1-Infected
Cells
We took an unbiased, Ingenuity Pathway Analysis (IPA)
approach to analyze the host signaling networks and pathways
modified during HIV-1 spread. This revealed that TCR signaling
in donor T cells was the top canonical pathway modified over
time during HIV-1 spread (TCR p value = 1.24 3 1012). This
was followed by CD28 (p value = 4.61 3 1011), inducible
T cell costimulator-inducible T cell costimulatory ligand (iCOS-
iCOSL) (p value = 5.5 3 109), and actin cytoskeleton signaling
(p value = 1.23 108) (Figure 1B; Table S2). In uninfected target
T cells, the top canonical pathways were TCR (p value = 5.39 3
109), CD28 (p value = 6.04 3 107), Cdc42 (p value = 8.73 3
107), RAC (p value = 1.023 107), and actin signaling (p value =
3.343 107) (Figure 1C; Table S2). Motif-X analysis of phospho-
sites predicted the kinases most active in HIV-1 donor cells as
CaMKII, PAK, and proline-directed kinases, compared to PAK,
CDK5, and proline-directed kinases in target cells (Figures S1E
and S1F).
The fact that TCR signaling was the most highly activated
pathway in infected cells is surprising because HIV-1 mediated
T cell-T cell contact during viral spread does not involve TCR-
pMHC (peptide major histocompatibility complex) interactions
and as such is antigen-independent. Rather it is driven by Env
expressed in infected cells engaging viral entry receptors (CD4
and CCR5 or CXCR4) on opposing cells during T cell-T cell inter-
actions with additional contributions from adhesion molecules
(LFA-1 and ICAM) (Chen et al., 2007; Jolly et al., 2004, 2007a;
Rudnicka et al., 2009; Sourisseau et al., 2007). Figure 2A graph-
ically summarizes the phosphoproteins we identified in HIV-1
donor cells mapped onto signaling pathways associated with
canonical T cell activation at T cell-APC contacts. This visual
representation highlights the significant overlap between the
well-established TCR/co-stimulatory signaling pathway and
phosphorylation changes identified in HIV-1 donor cells during
contact with targets.
To explore this further, we compared our phosphoproteome
data with studies where the TCR was directly cross-linked on
Jurkat T cells, and signaling was analyzed across similar time
points. We found a 44% overlap between the phosphorylation
profile of HIV-1 donor cells during co-culture with target cells
and TCR-specific responses reported by Chylek et al. (Chylek
et al., 2014) and a 30% overlap with Mayya et al. (Mayya et al.,
2009) (Figure 2B; Table S4-2). KEGG database analysis also
reported substantial overlap between our phosphoproteome
results and phosphorylation of TCR-associated proteins (Table
S4-1).
Interestingly, we identified multiple proteins in our data
with phosphorylation changes that mapped to early plasmaw phosphorylation changes. Colored outlines and shapes of proteins denote
iption factor, small molecule, and other).
nical pathways modified in HIV-1-infected cells (refer to Table S2) and those
al. (Chylek et al., 2014).
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membrane proximal (CD3, Lck, CD43, CD2AP, GADS, and talin)
and intermediate/late components of TCR signaling, as well
as downstream regulators of gene expression (ERK1/2, AKT,
ETS1, and NFAT) (Tables S1 and S2). Many of the residuesmodi-
fied were known activating sites (Tables S2-5 and S2-10). T cell
signaling modulates the host cell cytoskeleton and the protein
trafficking that is required for T cell activation and secretion of
effector molecules (Brownlie and Zamoyska, 2013; Gomez and
Billadeau, 2008). Consistent with the notion that HIV-1 cell-cell
spread is an active, cytoskeletal-dependent process and that
virus infection drives this process (Jolly et al., 2004), we found
dynamic phosphorylation changes to many actin regulators
(PAK1, CFL, PALLD, MYH10, VIM, and WAS), polarity proteins
(SCRIB) and components of vesicle trafficking and fusion
(SNAP23) (Table S2), most of which that have not been previ-
ously described as host cofactors for HIV-1 replication and
spread.
HIV-1 predominantly spreads at virus-induced cell-cell
contacts but can also disseminate less efficiently via classical
diffusion-limited cell-free infection. Comparative analysis of our
results obtained from target T cells with a study mapping phos-
phorylation in T cells exposed to cell-free virus (Wojcechowskyj
et al., 2013) showed a 23% overlap in modified proteins, with
41% of the phosphorylation changes in these proteins mapping
to the same site (Table S5). Since the molecular processes of
HIV-1 entry and the early steps of infection are similar between
cell-free and cell-cell spread (Jolly et al., 2004; Jolly and Satten-
tau, 2004), some overlap is expected; however, differences
implicate additional signaling pathways specifically activated
during T cell-T cell contact and other unique responses occur-
ring when target cells encounter greater numbers of incoming
virions during cell-cell spread (Jolly et al., 2004; Martin et al.,
2010; Sourisseau et al., 2007).
TCR Signaling by a Non-canonical Means Employs
Classical T Cell Kinases
Having identified changes in phosphorylation of key compo-
nents of classical T cell signaling during HIV-1 spread, which
strongly indicates activation, we sought to validate this observa-
tion directly using western blotting to visualize protein phos-
phorylation and quantified this from multiple experiments using
densitometry analysis (Figures 3, S4, and S5). Proteins were
chosen that represented upstream kinases, cytoskeletal pro-
teins, and transcriptional regulators involved in T cell receptor
signaling that showed dynamic phosphorylation changes at
defined sites that dictate protein function (e.g., LckY394,
PAK1S204, CFLS3, ERKT202/Y204, AKTT308, and AKTS473). Other
components of the top canonical pathways activated (e.g.,
ZAP70Y319 and LATY191) were also included. Figures 3A and 3B
shows that contact between HIV-1-infected and HIV-1-unin-
fected T cells increased phosphorylation of the actin regulators
PAK1S204 and CFLS3. While PAK1 activation was specific to
contacts mediated by HIV-1-infected cells, CFL phosphorylation
appeared to be infection-independent and was also triggered by
contact between uninfected T cells (Figures S4 and S5). How-
ever, as T cells do not usually form sustained cell-cell contacts
in the absence of retroviral infection (Jolly and Sattentau, 2004)
or previous antigenic stimulation (Sabatos et al., 2008), this1066 Cell Reports 18, 1062–1074, January 24, 2017may be unlikely to occur under normal conditions of transient
cell interactions. PAK1 influences cytoskeletal dynamics and
T cell activation and is activated through phosphorylation at
Ser204 via TCR-dependent (Yablonski et al., 1998) and TCR-in-
dependent mechanisms (Phee et al., 2005). CFL, a downstream
target of the PAK1 cascade, stimulates actin severance and
depolymerization to increase actin turnover and is inactivated
by LIMK phosphorylation at Ser3 (Yang et al., 1998), potentially
stabilizing cell-cell contacts. Modulation of cytoskeletal dy-
namics is thus consistent with the requirement for actin remod-
eling during immune cell interactions and HIV-1 cell-cell spread
(Jolly et al., 2004, 2007b; Rudnicka et al., 2009). Next, we exam-
ined Lck and ZAP70 (Figures 3C, 3D, S4, and S5), which are
TCR-proximal kinases and key initiators of T cell signaling
(Brownlie and Zamoyska, 2013; Iwashima et al., 1994). Lck ac-
tivity is regulated by multiple phosphorylation states (activating
site LckY394; inhibitory site LckY505) and intracellular localization
(Casas et al., 2014; Nika et al., 2010; Salmond et al., 2009).
ZAP70 activity is positively regulated by Y319 phosphorylation
(Di Bartolo et al., 1999). Consistent with activation of TCR
signaling, rapid and dynamic changes to both LckY394 and
ZAP70Y319 were seen over time during HIV-1-induced cell-cell
contact (Figures 3C, 3D, S4, and S5), with identical patterns of
phosphorylation indicative of Lck-dependent ZAP70 activation
(Brownlie and Zamoyska, 2013). A slight dip in Lck and ZAP70
phosphorylation was seen at 20 min, although the reasons for
this are unclear. By contrast, activation of LATY191 was un-
changed in both MS and western blotting (Figures 3E, S4, and
S5; Table S1). Supporting our phosphoproteome data showing
downstream propagation of signaling cascades (Figure 2),
strong activation of ERKT202/Y204 during HIV-mediated cell-cell
contact was observed by 40min (Figures 3F, S4, and S5). Finally,
having found phosphorylation of the serine/threonine kinase AKT
and a number of downstream targets by MS (e.g., TSC1,
TBS1D4, PTPN1, Girdin, GSK3b, and HTT; Table S2), we tested
phosphorylation of AKTT308 and AKTS473. AKTT308, which lies in
the activation loop of AKT and is most correlative with kinase
activity (Alessi et al., 1997), showed a 1.5-fold increase in phos-
phorylation during HIV-1-mediated cell-cell contact (Figures 3G,
S4, and S5). By contrast, AKTS473 that contributes to further
kinase function (Sarbassov et al., 2005), and phosphorylation
of additional downstream targets appeared to be activated by
cell-cell contact independent of HIV-1 infection (Figures 3G,
S4, and S5).
Next, we extended the analyses to primary CD4 T cells purified
from healthy donors that were infected with HIV-1 ex vivo and
mixed with autologous CD4 T cells (Figures 3 and S5) as well
as mock-infected controls (Figures S4 and S5). Primary T cells
showed similar patterns of HIV-dependent, contact-mediated
phosphorylation over time but more rapid propagation of
signaling and more robust AKTT308 activation (Figures 3 and
S5), in agreement with previous data indicating HIV-1-infected
primary T cells are highly responsive to contact with target cells
(Groppelli et al., 2015). However, western blotting of total cell
lysates from primary cells did not reveal global changes in
Lck phosphorylation (Figures 3C and S5), consistent with high
basal levels of Lck phosphorylation in primary T cells (Nika
et al., 2010).
Figure 3. T Cell Receptor Signaling Drives HIV-1 Cell-Cell Spread
(A–H) Protein phosphorylation analysis by western blotting of lysates prepared from contacts between infected and uninfected T cells. Blots are representative of
at least two independent experiments. Antibodies specific for phosphorylated and total protein were used (A–G). HIV-1 Gag p55 confirms infection and equal
loading (H). The left panels show HIV-1 infected Jurkat T cells and uninfected Jurkat targets. The middle panels show HIV-1-infected primary CD4 T cells and
uninfected primary CD4 targets. The right panels show HIV-1 infected TCR-negative Jurkat T cells and uninfected WT Jurkat targets.
(I–L) Jurkat T cells were infected with VSV-G pseudotyped HIV-1. (I) Infected cells were quantified by flow cytometry. (J) Virus budding wasmeasured by Gag p24
ELISA. (K) Virion infectivity was measured by luciferase assay. (L) Quantification of cell-cell spread by real-time qPCR. Values show the fold-increase in viral DNA
over time compared to the baseline (0 hr), reflecting de novo reverse transcription in newly infected target cells.
(M) Quantification of cell-cell spread from infected WT, TCR-negative, and TCR-reconstituted cells measured by luciferase assay (RLU, relative light units).
(N) HIV-1-infected TCR-negative cells form fewer VSs (number of cell-cell contacts analyzed: WT, n = 29; TCR negative, n = 32).
(O) The TCR complex component CD3 is co-polarized with HIV-1 Env at the interface formed between HIV-1-infected primary T cells (bottom, asterisk) and
autologous target T cells (top). Scale bar, 5 mm.
(P) Quantification of the frequency of CD3 enrichment at the contact zone (number of cell-cell contacts analyzed: donor A, n = 41; donor B, n = 13).
Data represent mean ± SEM from two or three independent experiments. **p < 0.005; ***p < 0.001. See also Figures S4 and S5.
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The T Cell Receptor Is Required for Efficient HIV-1
Spread at T Cell Contacts
Signaling through the TCR is considered a tightly controlled
checkpoint to ensure T cell activation only occurs in response
to foreign antigen displayed by MHC. It is therefore striking
that antigen-independent, HIV-1-induced T cell-T cell inter-
actions should trigger classical TCR signaling cascades and
phosphorylation of numerous pathway components. To probe
the relationship between the TCR complex and contact-induced
activation of signaling in HIV-1 donor cells, TCR/CD3-negative
T cells were infected with HIV-1 and phosphorylation examined.
Notably, HIV-1-infected TCR-negative cells did not phosphory-
late PAK, Lck, ZAP70, or ERK in response to contact with target
T cells (Figures 3A, 3C, 3D, 3F, and S5), implicating the TCR in
signal activation. As a control, we confirmed TCR-negative cells
retained expression of Lck (Figure S4L) and that HIV-1-infected
cells did not downregulate cell-surface expression of the TCR/
CD3 complex (Figures S4J and S4K).
Seeking a role for TCR-dependent signaling in HIV-1 spread,
TCR-negative cells were infected and their ability to support
viral replication measured. TCR-negative cells were readily
susceptible to initial infection with HIV-1 (Figure 3I) and
showed no defect in cell-free virus production over a single
round of infection, as measured by quantifying release of viral
Gag (budding) and particle infectivity (Figures 3J and 3K).
Remarkably, when infected cells were incubated with wild-
type target T cells, we observed a significant defect in their
ability to transmit virus by cell-cell spread (Figure 3L). Recon-
stituting TCR expression using lentiviral transduction resulted
in >85% of cells expressing the TCR complex at the cell
surface (Figure S4I) and rescued HIV-1 cell-cell spread (Fig-
ure 3M). Failure of TCR-negative cells to efficiently transmit vi-
rus by cell-cell spread indicates an important role for the TCR
in VS formation and virus spread. Quantitative immunofluores-
cence microscopy (Figure 3N) revealed TCR-negative cells
were indeed impaired in VS formation and could not recruit
the viral structural proteins Gag and Env to sites of cell-cell
contact to polarize viral budding toward the target cell (Env
enrichment at contact site: wild-type (WT), 10-fold ± 2.6-fold,
n = 17; TCR negative, 1.6-fold ± 0.5-fold, n = 16; Gag enrich-
ment at contact site: WT, 18.3-fold ± 5.7-fold, n = 14; TCR
negative, 1.7-fold ± 0.3-fold, n = 16).
We hypothesized that close and sustained contact between
infected and uninfected cells may be inducing TCR coalescence
at the contact site as amechanism of receptor triggering (van der
Merwe and Dushek, 2011). In support of this model, analysis of
contacts formed between HIV-1-infected primary T cells and
autologous uninfected T cells showed that 70%of VSs displayed
co-enrichment of the TCR and Env on infected cells at the con-
tact zone (Figures 3O and 3P), despite the absence of direct
antigen-dependent TCR engagement by opposing uninfected
targets. Quantification of fluorescence revealed the TCR was
enriched 3.3-fold ± 0.6-fold and Env 6.9-fold ± 1.5-fold at the
contact site (n = 20).
Lck and ZAP70 Support HIV-1 Spread between T Cells
The kinase Lck is a key upstream initiator of TCR signaling and
activation of cytoskeletal dynamics at immune cell contacts1068 Cell Reports 18, 1062–1074, January 24, 2017(Danielian et al., 1991; Iwashima et al., 1994; Lovatt et al.,
2006; Nika et al., 2010; Straus andWeiss, 1992). To test whether
signaling during HIV-1-induced T cell contact was Lck depen-
dent, Lck-negative JCAM1.6 cells were infected with virus and
mixed with wild-type target T cells, and protein phosphorylation
was analyzed. Figures 4A–4G and quantification of western blots
(Figure S5) revealed that Lck-negative HIV-1-infected cells were
unable to initiate signaling and activate PAK1S204, ZAP70Y319,
ERKT202/Y204, and AKTT308, whereas CFL remained responsive.
To examine whether Lck and the downstream kinase ZAP70
contribute functionally to HIV-1 replication, Lck- and ZAP70-
negative T cells were infected, and virus assembly, budding,
and spreadwere quantified.We used VSV-G-pseudotyped virus
to overcome variable expression of the receptor CD4. Notably,
both Lck- and ZAP70-negative Jurkat cells failed to support
efficient cell-cell spread (Figure 4L). In agreement with data us-
ing TCR-defective cells, impaired cell-cell spread in Lck- and
ZAP70-deficient Jurkat cells was not due to a block in virus
infection or a defect in virus production, since the cell-free virus
budding and particle infectivity were equivalent to that of WT
Jurkat cells (Figures 4I and 4K). However, as expected, there
was a significant defect in VS formation and failure to recruit
Env and Gag to the contact interface (Figures 4M and 4N)
but no effect on cell-cell contact (WT, 27%; Lck negative,
20%; and ZAP70 negative, 19%; p > 0.05), demonstrating
that Lck and ZAP70 are not mediating their effect through
altering T cell-T cell interactions. Reconstituting cells with
exogenous Lck and ZAP70 (Figures S4M and S4N) significantly
increased cell-cell spread (Figure 4l) and restored VS formation
(Figure 4O) as measured by Env and Gag recruitment to the
cell-cell interface (Env enrichment at contact site: Lck nega-
tive, 2.6-fold ± 1.5-fold, n = 15; Lck reconstituted, 9.5-fold ±
4.5-fold, n = 15; ZAP70 negative, 3.1-fold ± 1.2-fold, n = 14;
ZAP70 reconstituted, 10.7-fold ± 3.6-fold, n = 12; Gag enrich-
ment at contact site: Lck negative, 1.9-fold ± 0.8-fold, n = 15;
Lck reconstituted, 5.6-fold ± 1.8-fold, n = 17; ZAP70 negative,
2.4-fold ± 0.7-fold, n = 16; ZAP70 reconstituted, 14.5-fold ±
6.6-fold, n = 12).
Viral Determinants of Contact-Induced T Cell Signaling
The viral determinants of contact-induced antigen-indepen-
dent T cell signaling remained unclear. HIV-1 Env expressed
on the surface of infected T cells binds cellular entry receptors
on opposing cells, leading to sustained cell-cell contact,
plasma membrane remodeling, receptor clustering, and VS
formation (Jolly et al., 2004). Consistent with antigen-indepen-
dent T cell signaling being driven by close, sustained physical
cell contact mediated by Env-CD4/coreceptor interactions,
T cells infected with Env-deleted VSV-G-pseudotyped virus
(HIV+ DEnv) did not activate phosphorylation of T cell signaling
components following incubation with target cells, with the
exception of CFL and AKT473 (Figures 5A–5F and S5). Similar
results were observed when primary CD4 T cells were infected
with DEnv VSV-G-pseudotyped virus (Figures S4 and S5).
We postulated that failure to activate signaling was because
TCR clustering did not occur in the absence of HIV-1 Env-
mediated cell-cell contact. Concordantly, we observed a sig-
nificant reduction in the number of cell-cell contacts displaying
Figure 4. T Cell Kinases Lck and ZAP70 Are Required for Efficient HIV-1 Spread
(A–H) Protein phosphorylation analysis by western blotting of lysates (A–G) (see Figure 3) prepared from contacts between HIV-1 infected Lck-negative Jurkat
T cells and uninfected wild-type Jurkat targets. Blots are representative of at least two independent experiments.
(I) Quantification of infection by flow cytometry.
(J) Quantification of cell-free virus budding by Gag p24 ELISA.
(K) Particle infectivity determined by reporter cell luciferase assay.
(L) Quantification of HIV-1 cell-cell spread from infected Jurkat T cells by real-time qPCR.
(M) Percentage of infected Jurkat (Gag, green; Env, red) and uninfected target cells (dye-labeled, blue) contacts showing polarization of Env and Gag to the
contact zone (percentage of virological synapses [VSs]) (number of cell-cell contacts analyzed: WT, n = 30; Lck negative, n = 30; ZAP70 negative, n = 30).
(N) Representative images of normal VSs (WT) and defective VSs (Lck and ZAP70 negative) formed between an HIV-1-infected Jurkat T cell (bottom, asterisk) and
an uninfected target T cell (top).
(O) Reconstituting Lck and ZAP70 expression restores VS formation (number of cell-cell contacts analyzed: WT, n = 59; Lck negative, n = 58; Lck positive, n = 48;
ZAP70 negative, n = 60; ZAP70 positive, n = 38).
Data represent mean ± SEM from three independent experiments. **p < 0.005; ***p < 0.001. See also Figures S4 and S5.TCR clustering in the absence of HIV-1 Env expression on
infected primary CD4 T cells (Figure 5I), with only 16% of
contacts showing TCR enrichment when cells were infected
with HIV DEnv virus compared to 70% using WT virus (p <
0.001).The HIV-1 accessory protein Nef has been reported to modu-
late T cell signaling (Pan et al., 2012; Simmons et al., 2001) and
induce hyper-responsiveness to stimulation (Hanna et al.,
1998; Schrager and Marsh, 1999; Wang et al., 2000). To test
whether Nef was potentiating antigen-independent signaling,Cell Reports 18, 1062–1074, January 24, 2017 1069
Figure 5. Viral Determinants of Contact-Induced TCR Signaling
(A–H) Protein phosphorylation was determined by western blotting (A–G) (see Figure 3). Blots are representative of at least two independent experiments. The left
panels show Jurkat T cells infectedwith VSV-G-pseudotyped HIV-1 containing a frameshift mutation in Env (DEnv) and incubated with uninfected target cells. The
right panels show Jurkat T cells infected with VSV-G-pseudotyped DNef HIV-1 and incubated with uninfected target cells.
(I) Quantification of the frequency of CD3 enrichment at the contact zone using viral mutants (black filled, percentage of CD3-enriched contacts; gray filled,
percentage of CD3-nonenriched contacts) (number of cell-cell contacts analyzed: WT, n = 54; DEnv, n = 31; DNef, n = 30). Data from two independent primary
T cell donors with the SEM.
(J) Model depicting contact-induced activation of TCR signaling during HIV-1 cell-cell spread.
See also Figures S4 and S5.T cells were infected with Nef-deleted virus and signaling exam-
ined. Figures 5A–5G shows that deletion of Nef resulted in failure
to activate ERKT202/Y204, LckY394, ZAP70Y319, and PAK1S204
following incubation with target cells, with AKTT308 phosphoryla-
tion remaining responsive to cell-cell contact (Figures 5 and S5).
However, in contrast to Env, Nef appeared dispensable for TCR
clustering at the VS (Figure 5I), suggesting Nef potentiation of
signaling acts downstream of cell-cell contact. Taken together,
these data demonstrate HIV-1 infection induces antigen-inde-
pendent TCR signaling that is activated by Env-dependent
cell-cell contact and further potentiated by the HIV-1 virulence
factor Nef.1070 Cell Reports 18, 1062–1074, January 24, 2017DISCUSSION
Here, we have developed an approach to globally map phos-
phorylation-based dynamic signaling events in complex mixed
cell populations and performed an analysis of host cell signaling
pathways that are manipulated during HIV-1 spread between
CD4 T cells. Cell-cell spread of HIV-1 potently enhances viral
dissemination (H€ubner et al., 2009; Jolly et al., 2007b; Martin
et al., 2010; Sourisseau et al., 2007), but many aspects of this
host-pathogen interaction remain obscure. Our identification
of >200 host cell factors that are manipulated during highly
efficient HIV-1 spread is thus timely and provides a wealth of
information with implications for pathogenesis. Furthermore, the
experimental approach we describe has broad applicability and
can be readily applied to complex biological analyses such as
signaling during intercellular communication or to define host
cell responses to the sequential steps of pathogen replication.
Notably, we make the unexpected discovery that HIV-1 sub-
verts classical TCR signaling pathways independently of antigen
during cell-cell contact to drive viral spread from infected to
uninfected T cells. Specifically, we found that cell-cell contact
mediated by Env uniquely activates the TCR/CD3 complex and
downstream kinases Lck and ZAP70 in infected T cells and that
this process is required to transmit virus to neighboring cells.
We propose a paradigm (model) of TCR signaling (Figure 5J)
in which the close apposition and sustained physical con-
tact between HIV-1-infected and -uninfected T cells, which are
mediated by Env-receptor interactions and remodel the
synaptic plasma membrane, lead to aggregation and enrich-
ment of the TCR/CD3 complex at the contact site and initiation
of TCR signaling. Specifically, the presence of plasma-mem-
brane-exposed Env engaging CD4 and coreceptor on target cells
results in coalescence and enrichment of cross-linked Env at the
VS (Figures 3and4) (Jolly et al., 2004).Concomitantly,weobserve
Env-dependent clustering of TCR-containing plasma membrane
microdomains at the cell-cell interface (Figures 3 and 5) and acti-
vation of Lck-dependent signaling. We propose that activating
signaling could then drive the recruitment of additional Env and
Gag to the contact zone aswe found here by quantifying viral pro-
tein enrichment (potentially via cytoskeletal remodeling and acti-
vation of intracellular transport pathways), resulting in polarized
HIV-1 assembly and budding of virions across the synaptic space
toward the engaged target cell. The TCR, Lck and ZAP70
comprise a triad of early T cell signaling initiators that trigger cyto-
skeletal remodeling and intracellular trafficking. Consistent with
this, thesehostproteinswereall required todirect theactive trans-
port of HIV-1 structural proteins Env and Gag to sites of cell-cell
contact. In support of our results, ZAP70 has previously been
implicated in HIV-1 spread and VS formation (Sol-Foulon et al.,
2007). While our data reveal a compelling role for antigen-inde-
pendent TCR triggering for synaptic signaling, VS formation,
and rapid HIV-1 transmission, we cannot discount the contribu-
tion of other cell-surface receptors, such as LFA-1 (which is re-
cruited to both the immunological and virological synapses) or
indeed other as-yet-unidentified pathways, in contact-induced
signaling during HIV-1 spread. Unfortunately, ablation of LFA-1
expression significantly impaired the stability of cell-cell contacts
(datanot shown),meaningwewereunable to assess thecontribu-
tion of adhesionmolecules to signaling. Futureworkwill undoubt-
edly be informative to further define these processes.
Jurkat cells have been used extensively to interrogate T cell
signaling and HIV-1 cell-cell spread; however, they are constitu-
tively activated and can lack components of the T cell signaling
machinery. For example, PTEN deficiency results in higher levels
of basal AKT activation in transformed cell lines, including Jurkats
(Xu et al., 2002). This is reflected in our results, where we detected
more robust contact-dependent AKTT308 phosphorylation in pri-
mary T cells compared to Jurkat cells. By contrast, primary
T cells show high basal Lck activation (Nika et al., 2010), making
it difficult to detect differential Lck phosphorylation by westernblotting, as we also observed. However, having performed exper-
iments using both Jurkats and primary T cells,weprovide compel-
lingdataattesting tocontact-mediatedactivationofTcell signaling
that is dependent onHIV-1 infection and Env expression. This was
supported by our observation that the TCR complex is recruited to
the VS formed between primary T cells in an Env-dependent
manner. Furthermore,cell lines lacking theTCRorLckwereunable
to activate signaling, form VSs, and drive viral spread. That we
were previously unable to detect significant enrichment of CD3
at the VS in an earlier study using T cell lines (Jolly et al., 2004) is
likely to due to suboptimal staining conditions and the choice of
cells in that study. Here, we find that cell permeabilization prior
to staining with commercial antibody and the use of primary CD4
T cells greatly improved the intensity of CD3 staining and revealed
robust and reproducible enrichment of TCR/CD3 at the VS.
Our simultaneous analysis of phosphorylation changes in
HIV-1-infected and HIV-1-uninfected T cells during viral dis-
semination revealed widespread modulation of host cell path-
ways by HIV-1 that support viral replication by activating unique
replication-enhancing signals. In addition to the requirement for
physical cell-cell contact mediated by Env, the viral accessory
protein Nef was necessary, but not sufficient, for contact-induced
TCR signaling. Nef is multifunctional modulator of T cell signaling
(Arhel and Kirchhoff, 2009) that has been implicated in aberrant
Lck activation independent of the TCR during T cell-APC interac-
tions and perturbation of immune synapse formation (Pan et al.,
2012; Thoulouze et al., 2006). However, conflicting reports about
Nef’s ability to potentiate or suppress signalingmeans the biolog-
ical consequences for viral spread remain poorly understood.
Intriguingly, the Nef proteins of HIV-1 and its ancestor, SIVcpz, un-
like most other simian immunodeficiency viruses (SIVs), do not
downregulate expression of the TCR on infected T cells (Arhel
et al., 2009; Schindler et al., 2006). Why HIV-1 does not employ
this potential immune-evasion strategy has remained enigmatic.
We propose that HIV-1 has instead evolved to preserve expres-
sion and exploit the TCR through molecular reprogramming of
classical T cell signaling pathways during cell-cell contact, allow-
ing for optimal viral replication and spread between human CD4
Tcells. ThatmostSIVsdownregulate theTCRon infectedcells rai-
ses the intriguing question of how those viruses disseminate be-
tween cells. Whether they exploit an alternate mechanism for
driving spread between T cells in contact, and if this contributes
to differences in immune activation and disease pathogenesis
seen in natural SIV infections (Kirchhoff, 2009), is unknown. Future
studies to address this would be extremely interesting and un-
doubtedly shed new light on unresolved questions surrounding
the pathogenicity of lentiviral infection.
We envisage that the insights our data provide into the manip-
ulation of T cell signaling by HIV-1, coupledwith the identification
of >200 host cell factors modified during viral spread, will inform
future studies aimed at defining the molecular processes regu-
lating successful HIV-1 replication in both infected and suscep-
tible target T cells and the associated immunological dysfunction
causing AIDS. In an era in which ex vivo manipulation of T cells is
increasingly deployed for diverse immunotherapy strategies, our
findings have clear importance beyond the sphere of HIV-1 and
define concepts of T cell activation that could be considered in
future immunomodulatory strategies.Cell Reports 18, 1062–1074, January 24, 2017 1071
EXPERIMENTAL PROCEDURES
Cell Culture
Jurkat T cell lines and HeLa TZM-bl and 293T cells were cultured, infected, or
transduced as described in Supplemental Experimental Procedures. Primary
CD4 T cells were isolated from peripheral blood of healthy donors by Ficoll
gradient centrifugation and negative selection (Miltenyi Biotec), cultured, and
infected as described in Supplemental Experimental Procedures.
Virus Production and Infection
HIV-1 was prepared from the molecular clone pNL4.3 (NIH AIDS Reagent
and Reference Program [ARRP]) by transfecting 293T cells using Fugene 6
(Promega) and infectious virus titered on HeLa TZM-bl cells using Bright-Glo
Luciferase assay (Promega). Jurkat cells or primary CD4 T cells were infected
with HIV-1 NL4.3 by spinoculation (Groppelli et al., 2015) and incubated for
48 hr prior to use. Alternatively, cells were infected with VSV-G-pseudotyped
virus generated by transfecting 293T cells with pNL4.3, pNL4.3 DNef, or
pNL4.3 DEnv and pMDG (Naldini et al., 1996). Infection was quantified by
flow cytometry staining for intracellular Gag (Groppelli et al., 2015).
Quantitative Phosphoproteomics and Mass Spectrometry Analysis
Triple SILACwasperformedonJurkatCE6-1 cells and incorporation confirmed
by MS. Jurkat cells labeled with heavy (R10K8) amino acids were infected with
HIV-1 and mixed with uninfected target Jurkat cells labeled with light (R0K0)
amino acids. Medium-labeled (R6K4) cells were used as an internal reference.
Infected and uninfected T cells weremixed and incubated for 0, 5, 20, or 40min
prior to lysis. All time-point samples were buffer exchanged, reduced, and
alkylated and subsequently digested using filter aided sample preparation
(FASP). Digested peptides were fractionated via hydrophilic interaction chro-
matography (HILIC) and enriched for phosphopeptides using titanium immobi-
lized metal affinity chromatography (Ti-IMAC) and analyzed by high-resolution
nano-liquid chromatography electrospray ionization (nano-LC ESI) MS/MS.
Raw MS data were processed using MaxQuant for protein assignment, quan-
tification of peptides, phosphorylation, and phosphosite localization. Refer to
Supplemental Experimental Procedures for more information.
SDS-PAGE and Western Blotting
Cell lysates were prepared as described for MS. Proteins from an equal
number of cells were separated by SDS-PAGE, transferred to nitrocellulose,
and subjected to western blotting for total and phosphorylated proteins as
described in Supplemental Experimental Procedures. Blots are representative
of two or three independent experiments. Densitometry quantification of
bands was performed using ImageJ. The band intensity for each phosphopro-
tein was normalized to the corresponding total protein at each time point and
plotted as the mean fold change in protein phosphorylation (where t = 0 min
was normalized to 1) from multiple experiments.
HIV-1 Replication Assays
Jurkat T cells were infected with VSV-G-pseudotyped HIV-1. Forty-eight hr
post-infection, viral supernatants were harvested and Gagp24 quantified by
ELISA (Jolly et al., 2007b). Virion infectivity was determined by luciferase assay
using HeLa TZM-bl reporter cells. HIV-1 cell-cell spread was measured by
quantitative real-time PCR (Jolly et al., 2007b; Martin et al., 2010), and data
are shown as the fold increase in HIV-1 DNA compared to the albumin house-
keeping gene and normalized to baseline (0 hr), reflecting de novo reverse tran-
scription in newly infected target T cells during cell-cell spread. Alternatively,
Jurkat 1G5 target T cells containing a luciferase reporter gene driven by the
HIV-1 long terminal repeat (LTR) were used and cell-cell spread measured
by luminescence assay (Groppelli et al., 2015).
Immunofluorescence Microscopy
Quantification of T cell-T cell contacts and VS was performed as described
previously (Jolly et al., 2004). Conjugates were defined as two closely apposed
cells consisting of one HIV-1-infected T cell and one target T cell. VSs were
defined as conjugates showing enrichment of HIV-1 Env and Gag to the site
of cell-cell contact (Jolly et al., 2004; Rudnicka et al., 2009). Images were ac-
quired using the DeltaVision ELITE Image Restoration Microscope (Applied1072 Cell Reports 18, 1062–1074, January 24, 2017Precision) coupled to an inverted Olympus IX71 microscope and a CoolSNAP
HQ2 camera, deconvolved with softWoRx 5.0 and processed using Huygens
Professional v4.0 and Adobe Photoshop C3. Quantification of fluorescence
intensity was performed using ImageJ. A region of interest at the contact
site (ROI 1) was selected and compared to a region on the opposite side of
the cell (ROI 2). The integrated density was adjusted for the size of region of
interest and for background, and the fold enrichment of fluorescence signal
at the contact zone was determined for at least 20 contacts from two inde-
pendent experiments.
Statistical Analysis
Statistical significance was calculated using the Student’s t test or the
Mann-Whitney test. For multiple comparisons, statistical significance was
calculated using the parametric ANOVA test with Bonferroni correction. Signifi-
cance was assumed when p < 0.05. All tests were carried out in GraphPad
Prism 6 software.
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Figure S1 related to Figure 1. Phosphoproteomics screen with bioinformatics analysis of coverage. A SILAC labeled HIV-1 
infected and uninfected Jurkat T cells were mixed and incubated for different periods of time before being lysed and analyzed by mass 
spectrometry. The number of proteins with mapped phosphorylation site changes (differentially expressed >1.5 fold over time, 0/5 
min, 20/5 min and 40/5 min) in HIV-1 infected donor T cells and target T cells identified in experiment 1 and confirmed in 
experiment 2. Inset: Flow cytometry quantification of HIV-1 infection for experiment 1 (black line) and 2 (grey line) compared to 
uninfected cells (filled) measured by intracellular Gag staining. B Overlap between proteins identified in the total proteome and 
phosphoproteome analysis. C Subcellular localization of proteins identified in the phosphoproteome analysis combined for HIV-1 
infected donor T cells and target T cells. D Geneontology analysis (PANTHER) of protein function for phosphoproteome analysis 
combined for HIV-1 infected donor and target T cells. E and F Kinase motif analysis. Top putative kinase motifs and kinases 
identified using Motif-x to have a change in phosphorylation over 40 minutes in HIV-1 infected donor T cells (E) and uninfected 
target T cells (F). 
Figure S2 related to Figure 1.  Distribution of phosphopeptides in HIV-1 infected T cells and uninfected target cells. A and C 
Distribution of phosphopeptides identified in HIV-1+ donor (A) and target cell (C) samples in experiment 1 based on fold change 
(log2) for all non-redundant phosphopeptides identified. B and D. Frequency distributions of 0 min/5 min, 20 min/5 min and 40 min/5 
min SILAC fold change (log2) in the HIV-1+ donor (B) and target cells (D) sample. E and F GProX cluster analysis depicting 
distinct groups of kinetically similar responsive proteins. E HIV-1 infected T cells. F Uninfected target cells. Phosphopeptides 
showing a >2 fold change in phosphorylation over 40 min were subjected to unsupervised clustering with the Fuzzy c-means algorithm. 
Eight distinct patterns of dynamic changes could be classified, whereby the number of proteins included in each cluster is indicated. 
Color-coded membership represents how well a single protein pattern fits with the general profile of the cluster. 
Figure S3 related to Figure 1. Replicate experiments show reproducible phosphopeptide distribution. Distribution of 
phosphopeptides identified in the HIV-1+ donor cells (A and B) and the uninfected target T cells (C and D) based on their average 
fold change (log2) for all non-redundant phosphopeptides identified. Refer to legend in Figure S2. E and F Measurement of SILAC 
reproducibility between replicate experiments. E HIV-1+ donor cells. F Uninfected target T cells. For each time point, the y-axis 
indicates the relative phosphopeptide abundance measured in experiment 1 and the x-axis experiment 2. 
Figure S4 related to Figure 3, 4 and 5. Western blotting of uninfected mock controls and Env infected primary T cells. Protein 
phosphorylation was determined by western blotting as described for Fig. 3. Left panel = uninfected Jurkat T cells incubated with 
uninfected Jurkat target cells. Middle panel = uninfected primary CD4 T cells incubated with uninfected primary CD4 target T cells. Right 
panel = primary CD4 T cells infected with VSV-G pseudotyped Env HIV-1 and incubated with uninfected primary CD4 target T cells. ND 
= not done. I-N Validation of Jurkat mutant cell lines and reconstitution. I Flow cytometry analysis of TCR plasma membrane 
expression on Jurkat T cells. Unstained Jurkat T cells (grey filled), TCR-negative J.RT3-T3.5 Jurkat cells (grey line), WT TCR+ve Jurkat 
cells (black dotted line) and TCR-reconstituted J.RT3-T3.5 Jurkat cells (black solid line). J HIV infection does not downregulate cell 
surface TCR expression on Jurkat T cells. Unstained Jurkat T cells (grey filled), uninfected Jurkat T cells (grey line) and HIV-1 infected 
Jurkat T cells (black line). K HIV infection does not downregulate cell surface CD3 expression on Jurkat T cells. Unstained Jurkat T cells 
(grey filled), uninfected Jurkat T cells (grey line) and HIV-1 infected Jurkat T cells (black line). L Western blotting confirming that TCR-
negative J.RT3-T3.5 Jurkat cells retain expression of Lck and that HIV-1 infection does not modulate Lck levels. M-N Western blotting 
confirming the protein expression phenotype of Lck-negative (M) and ZAP70-negative (N) Jurkat T cells and reconstituted cell lines.
Figure S5 related to Figure 3, 4, 5 and S4. Densitometry quantification of 
western blots. Densitometry quantification of western blots was performed 
using Image J. The band intensity for each phosphoprotein was determined and 
normalized to the corresponding total protein for each time point for two or 
three independent experiments. Data are plotted as the mean fold change in 
protein phosphorylation over time where t=0min was normalized to 1. To aid 
visualization, phosphoproteins are plotted for each condition (A-I), with the 
exception of Lck505 (the inhibitory Lck site that remained unchanged) and 
AKT473 (activation was HIV infection independent) that are shown on separate 
graphs (J and K).  
 
Supplemental Tables. 
 
Table S1 related to Figures 1-4. All identifications from both phosphoproteome and proteome duplicate experiments. 
 
Table S2 related to Figures 1-4. Curated qualitative and quantitative data for all 4 time points from both 
phoshoproteome and proteome single and duplicate experiments.  
 
Table S3 related to Figures 1-4. Comparison of overlapping and unique phosphoproteins identified in HIV+ donor T 
cells and target T cells. 
 
Table S4 related to Figures 1 and 2. Comparison TCR signaling proteins (KEGG) identified in our study and previous 
dynamic phosphoproteomic studies using direct antibody-based TCR stimulation.  
 
Table S5 related to Figure 1. Comparison of phosphorylation changes identified in target T cells in this study compared 
to Wojcechowskyj et al., 2013. 
 
 
 
Supplemental Experimental Procedures 
 
Cell Culture 
Jurkat T cell lines clones E6-1 (American Type Culture Collection [ATCC] TIB-152); Lck-negative JCAM1.6 (Straus 
and Weiss, 1992); Lck-reconstituted JCAM1.6 (a gift from A. Weiss, UCSF, USA); ZAP70-negative JP116 (Williams 
et al., 1998); ZAP70-reconstituted JP116 (Williams et al., 1998); TCR/CD3 negative J.RT3-T3.5 (Ohashi et al., 1985) 
and LFA-1 negative b2.7 (Weber et al., 1997) were grown in RPMI 1640 medium (Invitrogen) supplemented with 10% 
(v/v) heat inactivated fetal calf serum (FCS) penicillin/streptomycin (100 U mL-1, 100 µg mL-1). J.RT3-T3.5 cells were 
reconstituted with TCR alpha and beta chain expression by transducing cells with lentivirus prepared by co-transfecting 
293T cells with the TCR expression plasmid (a gift from H. Stauss and E. Morris, UCL), Gag-pol packaging plasmid 
and VSV-G  (Naldini et al., 1996).  Primary CD4 T cells were isolated from peripheral blood of healthy donors by 
Ficoll gradient centrifugation and negative selection (Miltenyi Biotec). For virus infection, PBMC were activated in 
5µg/ml PHA and 10IU IL2 for 3 days and then cultured in RPMI 20% FCS (v/v) with 10IU IL2. For 
immunofluorescence, primary CD4 target T cells were prepared without activation. HeLa TZM-bl cells (Center for 
AIDS Reagents, National Institutes of Biological Standard and Control, UK (CFAR, NIBSC)) and HEK 293T cells 
(ATCC) and were maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with streptomycin, 
penicillin and 10% FCS.  
 
SDS-PAGE and Western blotting 
Cell lysates were prepared as described for MS. Proteins from an equal number of cells were separated by SDS-PAGE,  
transferred onto nitrocellulose and blocked in PBS with 0.05% Tween 20 (v/v) and 5% BSA (w/v). The following 
antibodies against phosphorylated and total proteins were used: pLckY394, pLckY505 and total Lck (Cell Signaling 
Technology, CST); pZAP70Y319 and total ZAP70 (CST and New England Biolabs); pLATY191 and total LAT (CST); 
pPAK1S204 and total PAK1 (Assaybiotech and New England Biolabs) pCFLS3 and total CFL (CST); pERK1/2T202/Y204 
and total ERK1/2 (CST); pAKTT308, pAKTS473 and total AKT (CST, Signalway Antibody and Biolegend) and HIV-1 
Gag p55/p24 (CFAR, NIBSC, UK). HIV-1 Nef antiserum was a gift from E. Potton (UCL). Primary antibody was 
detected using polyclonal goat anti-rabbit or anti-mouse HRP (Dako) and chemiluminescence was detected using ECL 
(GE Healthcare). Alternatively, blots were blocked overnight in PBS with and 5% skim milk (w/v), incubated with 
primary antibodies followed by goat anti-rabbit IRdye 800CW infrared secondary antibodies and imaged using an 
Odyssey Infrared Imager (LI-COR Biosciences). Blots are representative of two or three independent experiments. 
Densitometry quantification of bands was performed using Image J. The band intensity for each phosphoprotein was 
normalized to the corresponding total protein at each time point and plotted as the mean fold change in protein 
phosphorylation (where t=0min was normalized to 1) from multiple experiments.   
 
 
Quantitative phosphosphoproteomics and mass spectrometry  
SILAC labeling  
SILAC was performed on Jurkat CE6-1 using one of three labels (Silantes, Munich, Germany) in RPMI devoid of 
arginine and lysine (Thermo Fisher Scientific):  ‘light’ label L-arginine and L-lysine (R0K0); ‘medium’ label L-
arginine-13C6-14N4 and L-lysine-2H4 (R6K4); or ‘heavy’ label L-arginine-13C6-15N4 and L-lysine-13C6-15N4 (R10K8) 
supplemented with penicillin/streptomycin (100 U mL-1, 100 µg mL-1), 10% (v/v) in house dialyzed FCS using 3.5 kDa 
cut off dialysis membrane (Spectra/Por), 2mM GlutaMAX™-I (Gibco/Life technologies), 1 x MEM Vitamin Solution 
(Gibco/Life technologies), 1 x Insulin-Transferrin-Selenium (Gibco/Life technologies) and 1mM Sodium pyruvate 
(Sigma). For replicate SILAC experiments identical low passage cells maintained in non SILAC RPMI were washed 
and transferred using one of three SILAC labeled media and grown as described above for at least 6 doublings.  Initial 
seeding of 2 x 105 cells mL-1 in SILAC labeled media was used and upon reaching 3 doublings the cells were split down 
to 2 x 105 cells mL-1 and cultivated for a further 3 doublings in SILAC labeled media.   
 
Preparation of cell lysates from HIV-1 infected and uninfected T cell co-culture 
To avoid label bias two replicate experiments where a light and heavy label swap was conducted with the HIV-1 
infected donor and target (uninfected) T cells.  Dynamic phosphorylation changes upon conjugate formation between 
donor and target cells over 4 time points, 0, 5, 20 and 40 min were analyzed.  To enable the comparison across all 4 
time points for either donor or target cells for each experiment, both cell populations were independently labeled with 
the medium label, mixed for each time point and the samples were subsequently pooled together to make an internal 
reference and an equal amount spiked into each light/heavy VS time points. A large number of cells are required for a 
two tiered proteome and phosphoproteome analysis. A total of 2.4 x107 cells from 6 technical replicates for each light 
and heavy label per time point and 3 technical replicates for the donor/target labeled with medium label were all carried 
out in 6 well plates and combined based on cell count with the ratio of 1(light):1(medium pool):1(heavy) to give a total 
of 7.2 x 107 cells per time point. To do this, 6 well plates were coated with 0.0025% poly-L-lysine and 4 x106 target T 
cells were added to each coated well to form a monolayer of cells for 2h at 37°C.  Donor cells (4 x106 per well) were 
added to target T cell and briefly centrifuged for <30 sec to synchronize conjugates and incubated at 37°C for 5, 20 and 
40 min.  For 0 min time point donor cells were additionally treated with protease and phosphatase inhibitor cocktails 
cOmplete ULTRA Tablets (Roche) and Phosstop (Roche), respectively, for 15 min prior to being mixed with target 
cells and harvested immediately.  At the end of each time point the supernatant was removed and each technical 
replicate was lysed with 1mL 4% (w/v) SDS, 0.1M Tris-HCl pH 7.6 and 0.1M DTT supplemented with the 
aforementioned protease and phosphatase inhibitors.  Each sample was probe sonicated on ice to shear genomic content 
with 4 bursts of 15 sec with 60 sec rest on ice between each burst using amplitude of 20%.  The samples were then 
centrifuged at 12,000 x g for 20 min and technical replicates for each time point combined.  For each replicate 
experiment the medium labeled samples of all technical replicates from each time point were combined and 
subsequently all time point samples were further combined to create a pooled internal standard that was added to each 
light/heavy labeled time point. 
 
FASP 
Filter Aided Sample Preparation (FASP) was performed as previously described (Wisniewski et al., 2009).  Briefly, 
each of the time point samples (9mL) were heated at 95°C for 5 min then diluted with 60 ml UA buffer (100 mM Tris-
HCL, pH 8.5, 8 M urea) and subsequently loaded onto 4 individual Nanosep, 10K Omega spin filters in 300 µL lots 
(PALL).  Spin filters were centrifuged at 8000 x g repeatedly until all the supernatant from the different samples were 
filtered through. The filters were then washed three times with UA buffer, and proteins were alkylated by the addition 
of 150 µL of 50 mM iodoacetamide (Sigma).   Filters were then washed 5 times with UA buffer and proteins digested 
twice with sequencing-grade modified trypsin (Promega). Digestion with trypsin was carried out at 30oC in 100 µL of 
50mM NH4HCO3 to a final trypsin concentration of 0.18 µg µL-1 overnight and then for a further 6h in the same 
conditions. Filters were then washed with 500 mM NaCl and resulting peptides acidified with trifluoroacetic acid (TFA) 
in preparation for desalting. 
 
HILIC  
Eluted peptides were desalted using a Sep-Pak SPE C18 column (Waters) according to manufacturer’s instructions.  
The desalted peptides were dissolved in 80% (v/v) CH3CN with 0.1% (v/v) TFA and subsequently fractionated into 24 
fractions using a Hydrophilic Interaction Liquid Chromatography (HILIC) column (TSKgel Amide-80,4.6*250mm, 
5µm [Tosoh Biosciences, Germany]) on a Dionex HPLC (Ultimate 3000) system. The flow rate applied was 0.6mL 
min-1, varying concentrations of Buffer A: 0.1% (v/v) TFA in 18 milliQ H2O and Buffer B: 0.1% (v/v) TFA in CH3CN, 
were used to separate the peptides using the following gradient: 80%-80% B in 20 min, and then 80%B -70%B in 10 
min, and then 70%B -60%B in 30 min.  Each fraction was split in a 1:19 ratio for subsequent proteome and 
phosphoproteome analysis, respectively, and dried using a centrifugal evaporator (SpeedVac, ThermoSavant, Thermo 
Scientific) prior to mass spectrometry analysis.  
 
Phosphopeptide enrichment using Ti IMAC beads 
Phosphopeptides were batch enriched from each peptide fraction using 100µL of 10 mg mL-1 slurry of MagReSyn 
titanium immobilized metal affinity chromatography (Ti-IMAC) magnetic microspheres (ReSyn Biosciences Ltd, South 
Africa). The microspheres were firstly washed with 80µL 0.5% (v/v) NH4OH then washed 3 times with 200µL 80% 
(v/v) CH3CN with 1% (v/v) TFA. This was followed by 3 washes with 200µL of 1M glycolic acid, 80% (v/v) CH3CN, 
5% (v/v) TFA.  Each wash was for 2 min with shaking prior to magnetic separation to separate the microspheres from 
the liquid and the resulting liquid was discarded. Each sample was reconstituted with 100µL of a 1 M glycolic, acid 
80% (v/v) CH3CN, 5% (v/v) TFA.  The HILIC fractionated peptide samples and microspheres were then combined and 
shaken for 20 min at room temperature.  The microspheres were then initially washed with 200µL of 1 M glycolic, 80% 
(v/v) CH3CN, 5% (v/v) TFA followed by a further 3 washes of 200µL 80% (v/v) CH3CN, 1% (v/v) TFA.  As 
previously, washes were incubated for 2 min with shaking prior to magnetic separation and the liquid was discarded. 
The microspheres were then incubated for 2 min with 80µL of 0.5% (v/v) NH4OH and after magnetic separation the 
liquid was transferred to a tube containing 60µL of 10% (v/v) CH2O2. This was repeated a further 2 times pooling all 3 
elutions for each sample.  The samples were then dried as above using a SpeedVac. 
 
LC ESI MS/MS Analysis 
Trypsin-digested peptides, either enriched for phosphopeptides through Ti IMAC or not, were separated using an 
Ultimate 3000 RSLC (Thermo Scientific) nanoflow LC system.  On average 0.5 µg was loaded with a constant flow of 
5 µL mL-1 onto an Acclaim PepMap100 nanoViper C18 trap column (100 µm inner-diameter, 2cm; Thermo Scientific).  
After trap enrichment, peptides were eluted onto an EASY-Spray PepMap RSLC nanoViper, C18, 2 µm, 100 Å column 
(75 µm, 50 cm; ThermoScientific) with a linear gradient of 2–40% solvent B (80% [v/v] CH3CN with 0.08% [v/v] 
CH2O2) over 124 min with a constant flow of 300 nL min-1.  The HPLC system was coupled to a linear ion trap 
Orbitrap hybrid mass spectrometer (LTQ-Orbitrap Velos Pro, Thermo Scientific) via a nano-electrospray ion source 
(Thermo Scientific).  The spray voltage was set to 1.8 kV, and the temperature of the heated capillary was set to 250 °C.  
Full-scan MS survey spectra (m/z 335–1800) in profile mode were acquired in the Orbitrap with a resolution of 60,000 
after accumulation of 1,000,000 ions.  The fifteen most intense peptide ions from the preview scan in the Orbitrap were 
fragmented by collision-induced dissociation (normalized collision energy, 35%; activation Q, 0.250; and activation 
time, 10 ms) in the LTQ after the accumulation of 10,000 ions.  Maximal filling times were 500 ms for the full scans 
and 100 ms for the MS/MS scans.  Precursor ion charge state screening was enabled, and all unassigned charge states as 
well as singly charged species were rejected.  The lock mass option (445.120024) was enabled for survey scans to 
improve mass accuracy (Olsen et al., 2005).  For the phosphorylated samples MultiStage Activation (MSA) was 
enabled (neutral loss mass list – 24.49, 32.66, 48.99, 97.98). Data were acquired using the Xcalibur software.  
 
Quantification and bioinformatics analysis 
The raw mass spectrometric data files obtained for each experiment were collated into a single quantitated data set 
using MaxQuant (version 1.3.0.5) (Cox and Mann, 2008) and the Andromeda search engine software (Cox et al., 2011).  
Enzyme specificity was set to that of trypsin, allowing for cleavage N-terminal to proline residues and between aspartic 
acid and proline residues. Other parameters used were: (i) variable modifications, methionine oxidation, protein N-
acetylation, gln à pyro-glu, and Phospho (STY) – specifically for the phosphorylation site enrichment samples; (ii) 
fixed modifications, cysteine carbamidomethylation; (iii) database: target-decoy human MaxQuant (UniprotSwall-
human, downloaded 20141203); (iv) heavy labels: R6K4 and R10K8; (v) MS/MS tolerance: FTMS- 10ppm, ITMS- 0.6 
Da; (vi) minimum peptide length, 7; (vii) maximum missed cleavages, 2; (viii) maximum number of labeled amino 
acids, 3; (ix) false discovery rate, 1%; and (x) minimum number of peptides, 2.  Peptide ratios were calculated for each 
arginine- and/or lysine-containing peptide as the peak area of labeled arginine/lysine divided by the peak area of non-
labeled arginine/lysine for each single-scan mass spectrum.  Peptide ratios for all arginine- and lysine-containing 
peptides sequenced for each protein were averaged. Data were normalized using 1/median ratio value for each 
identified protein group per labelled sample.  Corrected phospho peptide ratios were calculated by dividing the 
phospho-peptide ratio by the equivalent normalised standard experiment protein ratio.  Network analysis was done 
through the use of QIAGEN’s Ingenuity®Pathway Analysis (IPA®, QIAGEN Redwood City, 
www.qiagen.com/ingenuity) and top pathways represented using Gephi graph and network analysis software (Bastian et 
al., 2009).   Canonical pathways analysis identified the pathways from the Ingenuity Pathways Analysis library of 
canonical pathways that were most significant to the data set. Molecules from the data set that met the cut-off of >1.5-
fold and were associated with a canonical pathway in Ingenuity’s Knowledge Base were considered for the analysis. 
The significance of the association between the data set and the canonical pathway was measured in two ways: (1) A 
ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules 
that map to the canonical pathway is displayed; (2) Fisher’s exact test was used to calculate a p-value determining the 
probability that the association between the genes in the data set and the canonical pathway is explained by chance 
alone. We used Gephi (https://gephi.org/users/publications/)	to graphically represent the molecular relationship between 
molecules that were generated from IPA. Molecules are represented as nodes, and the biological relationship between 
two nodes is represented as an edge (line). All edges are supported by at least one reference from the literature or from 
canonical information stored in the Ingenuity Pathways Knowledge Base. Human, mouse, and rat orthologs of a gene 
are stored as separate objects in the Ingenuity Pathways Knowledge Base, but they are represented as a single node in 
the network. 
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